RKER-012, a modified ActRIIB-Fc ligand trap with BMP sparing properties, attenuates pathological features of experimental pulmonary arterial hypertension - Top-Institutions - MDSpire

RKER-012, a modified ActRIIB-Fc ligand trap with BMP sparing properties, attenuates pathological features of experimental pulmonary arterial hypertension

  • By

  • R. Keith Babbs

  • Jeanne Ishimwe

  • Chris Materna

  • ffolliott M. Fisher

  • Tandicka Nurse

  • Cynthia Pinkus

  • Pritesh Jain

  • Kevin Dagbay

  • Rosa Grenha

  • Tyler Daman

  • Claire C. Tseng

  • Emily A. Ledoux

  • Evan Lema

  • Alana Gudelsky

  • Francis Wolenski

  • Harveen D. Natarajan

  • Lorena Lerner

  • Jennifer L. Lachey

  • Jasbir Seehra

  • Sachindra R. Joshi

  • June 24, 2026

  • 0 min

Share

Top Institutions in Pulmonary

Brief introduction explaining scope and methodology.

  • #1

    Stanford Health Care – Stanford University School of Medicine
    Stanford Health Care – Stanford University School of Medicine

    Stanford, California

    Key Differentiators

    • Pulmonology

  • #2

    Brigham and Women’s Hospital (BWH) – Harvard Medical School
    Brigham and Women’s Hospital (BWH) – Harvard Medical School

    Boston, Massachusetts

    Key Differentiators

    • Pulmonology

Original Source(s)

RKER-012, a modified ActRIIB-Fc ligand trap with BMP sparing properties, attenuates pathological features of experimental pulmonary arterial hypertension

  • by R. Keith Babbs, Jeanne Ishimwe, Chris Materna, ffolliott M. Fisher, Tandicka Nurse, Cynthia Pinkus, Pritesh Jain, Kevin Dagbay, Rosa Grenha, Tyler Daman, Claire C. Tseng, Emily A. Ledoux, Evan Lema, Alana Gudelsky, Francis Wolenski, Harveen D. Natarajan, Lorena Lerner, Jennifer L. Lachey, Jasbir Seehra, Sachindra R. Joshi

  • June 24, 2026

Related Content

Innate immune circuits in acute lung injury: macrophage plasticity, ILC crosstalk, and tissue repair failure

Beyond binary: rethinking subphenotyping in ARDS as a continuous spectrum

Performance of four large language models in addressing family-centered questions on morbidity and outcomes in patients supported by extracorporeal membrane oxygenation